125 related articles for article (PubMed ID: 17874352)
1. Reversible paroxetine-induced symptomatic hypothyroidism.
Takahashi M; Sawayama E; Sawayama T; Miyaoka H
Pharmacopsychiatry; 2007 Sep; 40(5):201-2. PubMed ID: 17874352
[No Abstract] [Full Text] [Related]
2. Reversible escitalopram-induced hypothyroidism.
Eker SS; Akkaya C; Ersoy C; Sarandol A; Kirli S
Gen Hosp Psychiatry; 2010; 32(5):559.e5-7. PubMed ID: 20851281
[TBL] [Abstract][Full Text] [Related]
3. Delirium and multiple electrolyte abnormalities associated with high dose paroxetine exposure.
Chuang YF; Chiu YL; Hwang TJ; Chu TS
Psychiatry Clin Neurosci; 2006 Oct; 60(5):642-3. PubMed ID: 16958954
[No Abstract] [Full Text] [Related]
4. Hallucination induced by paroxetine discontinuation in patients with major depressive disorders.
Yasui-Furukori N; Kaneko S
Psychiatry Clin Neurosci; 2011 Jun; 65(4):384-5. PubMed ID: 21489048
[TBL] [Abstract][Full Text] [Related]
5. Hypothyroidism induced by quetiapine: a case report.
Liappas J; Paparrigopoulos T; Mourikis I; Soldatos C
J Clin Psychopharmacol; 2006 Apr; 26(2):208-9. PubMed ID: 16633154
[No Abstract] [Full Text] [Related]
6. Effect of paroxetine on thyroid hormone levels in severely depressed patients.
König F; Hauger B; von Hippel C; Wolfersdorf M; Kaschka WP
Neuropsychobiology; 2000; 42(3):135-8. PubMed ID: 11015031
[TBL] [Abstract][Full Text] [Related]
7. Pruritus induced by interruption of paroxetine therapy.
Mazzatenta C; Peonia G; Martini P
Br J Dermatol; 2004 Apr; 150(4):787. PubMed ID: 15099390
[No Abstract] [Full Text] [Related]
8. Digitalis intoxication induced by paroxetine co-administration.
Yasui-Furukori N; Kaneko S
Lancet; 2006 Mar; 367(9512):788. PubMed ID: 16517279
[No Abstract] [Full Text] [Related]
9. Delirium induced by abrupt discontinuation of paroxetine.
Hayakawa Y; Sekine A; Shimizu T
J Neuropsychiatry Clin Neurosci; 2004; 16(1):119-20. PubMed ID: 14990771
[No Abstract] [Full Text] [Related]
10. Visual and auditory hallucinations during normal use of paroxetine for treatment of major depressive disorder.
Monji A; Kato T; Mizoguchi Y; Horikawa H; Seki Y; Kanba S
J Neuropsychiatry Clin Neurosci; 2011; 23(4):E14-5. PubMed ID: 22231326
[No Abstract] [Full Text] [Related]
11. Minor strokes related to paroxetine discontinuation in an elderly subject: emergent adverse events.
Ramasubbu R
Can J Psychiatry; 2003 May; 48(4):281-2. PubMed ID: 12776398
[No Abstract] [Full Text] [Related]
12. [Alopecia due to Seroxat therapy].
Umansky L; Dorevitch A; Sella A
Harefuah; 2000 Apr; 138(7):547-9, 614. PubMed ID: 10883182
[TBL] [Abstract][Full Text] [Related]
13. [A case of probable neuroleptic malignant syndrome induced by monotherapy with paroxetine].
Nishimura H; Kashima N
Seishin Shinkeigaku Zasshi; 2004; 106(6):723-6. PubMed ID: 15387267
[No Abstract] [Full Text] [Related]
14. Depression and psoriasis comorbidity. Treatment with paroxetine: two case reports.
Luis Blay S
Ann Clin Psychiatry; 2006; 18(4):271-2. PubMed ID: 17162628
[No Abstract] [Full Text] [Related]
15. Paroxetine-induced increase in metabolic end products of nitric oxide.
Lara N; Archer SL; Baker GB; Le Mellédo JM
J Clin Psychopharmacol; 2003 Aug; 23(4):408-12. PubMed ID: 12920419
[TBL] [Abstract][Full Text] [Related]
16. Odd odds.
Andrade C
J Clin Psychiatry; 2011 Nov; 72(11):1558-9; author reply 1559. PubMed ID: 22127198
[No Abstract] [Full Text] [Related]
17. Toxic epidermal necrolysis after paroxetine treatment.
Ahmed R; Eagleton C
N Z Med J; 2008 May; 121(1274):86-9. PubMed ID: 18535650
[TBL] [Abstract][Full Text] [Related]
18. Elevation of nortriptyline plasma levels after cotreatment with paroxetine and thioridazine.
Ghaemi SN; Kirkwood CK
J Clin Psychopharmacol; 1998 Aug; 18(4):342-3. PubMed ID: 9690702
[No Abstract] [Full Text] [Related]
19. Paroxetine and acute angle-closure glaucoma.
Bennett HG; Wyllie AM
Eye (Lond); 1999 Oct; 13 ( Pt 5)():691-2. PubMed ID: 10696339
[No Abstract] [Full Text] [Related]
20. Paroxetine associated hepatotoxicity: a report of 3 cases and a review of the literature.
Azaz-Livshits T; Hershko A; Ben-Chetrit E
Pharmacopsychiatry; 2002 May; 35(3):112-5. PubMed ID: 12107856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
